1. Hannon VM, Cunningham AJ, Hutchinson M, et al. Aspiration pneumonia and coma -- an unusual presentation of dystrophic myotonia. Can Anaesth Soc J, 1986,33(6):803-806.
[2]
2. Carver RT, Boyse L, Marciniak CM, et al. Myotonic dystrophy presenting as new-onset hand weakness and recurrent pneumonia in a patient with paraplegia: a case report. Arch Phys Med Rehabil, 2004, 85: 1896-1898.
[3]
3. Finsterer J, Rudnik-Schneborn S. Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy. Fortschr Neurol Psychiatr, 2015, 83(1): 9-17.
[4]
4. Meola G, Cardani R. Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms. Biochim Biophys Acta, 2015, 52(4): 594-606.
[5]
5. Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol, 2012, 11(10): 891-905.
[6]
6. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med, 2008, 358(25): 2688-2697.
[7]
7. Nadaj-Pakleza A, Usakowska A, Suek-Pi, et al. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients. Folia Morphologica, 2011, 70(2): 121-129.
9. Kamsteeg EJ, Kress W, Catalli C, et al. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet, 2012, 20(12): 1203-1208.
[10]
10. Meola G. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies. Acta Myologica, 2013, 32(3):154.
